MedPath

Hunazine Biotech S.L.

🇪🇸Spain
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Phase 2
Recruiting
Conditions
Cholera
Interventions
Drug: Placebo
First Posted Date
2024-01-05
Last Posted Date
2024-02-28
Lead Sponsor
Hunazine Biotech S.L.
Target Recruit Count
150
Registration Number
NCT06193408
Locations
🇧🇩

Icddr,b, Dhaka, Bangladesh

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.